➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
Merck
McKesson
AstraZeneca

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Sulfisoxazole - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sulfisoxazole and what is the scope of freedom to operate?

Sulfisoxazole is the generic ingredient in nine branded drugs marketed by Roche, Mk Labs, Alra, Parke Davis, Ani Pharms Inc, Aurolife Pharma Llc, Barr, Heather, Impax Labs, Lannett, Lederle, Pharmeral, Purepac Pharm, Roxane, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Solvay, and Sola Barnes Hind, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfisoxazole.

Summary for sulfisoxazole
Recent Clinical Trials for sulfisoxazole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4
University of LouisvillePhase 0

See all sulfisoxazole clinical trials

Medical Subject Heading (MeSH) Categories for sulfisoxazole

US Patents and Regulatory Information for sulfisoxazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane SULFISOXAZOLE sulfisoxazole TABLET;ORAL 080082-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche GANTRISIN sulfisoxazole diolamine OINTMENT;OPHTHALMIC 008414-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche GANTRISIN sulfisoxazole acetyl SYRUP;ORAL 009182-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche LIPO GANTRISIN sulfisoxazole acetyl EMULSION;ORAL 009182-009 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
Merck
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.